Regulatory & Legal

Charlesbank's strategic funding validates HBox’s 'clinic within a clinic' model, aiming to revolutionize care for high-risk chronic conditions.

Fortune 500 giant ARKO Corp. plans to take its petroleum wholesale business public, a strategic split aimed at unlocking value and focusing growth.

With a star-studded 2026 lineup and rapid global expansion, Barco's advanced HDR Lightsteering technology is poised to become the new premium cinema standard.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

A cancer research firm is betting its future on Zcash, recruiting the crypto's top minds. Is this the start of institutional adoption for privacy coins?

Researchers at Kanazawa University have developed engineered nanoparticles that can reprogram rogue immune cells, offering a targeted therapy for autoimmune diseases.

T'way Air launches aggressive year-end deals for Seoul and Jeju, sparking a price war among low-cost carriers on the popular Singapore-Korea travel route.

Tech billionaire and commercial astronaut Jared Isaacman is the new NASA chief. Can his entrepreneurial vision and private space experience reshape the agency?

Denarius Metals solidifies its Zancudo gold-silver project in Colombia by filing a key technical report, validating a major resource update.

Following PwC's resignation, the private credit firm's move to MNP signals a new chapter in its financial governance as it streamlines operations.

In a fierce biotech talent war, Senti Bio's new equity grant for a key hire signals a strategic push for its gene therapy pipeline amid market volatility.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

A new national scholarship champions medical integrity, yet its founder recently settled a major False Claims Act case, raising complex questions.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

A training intensive promises to turn teachers into six-figure consultants. But behind the bold claims, some educators question the high-stakes business model.

An expert shares urgent year-end tips on charitable giving, portfolio rebalancing, and college savings to maximize benefits before new tax laws take effect.

A new Commerce Dept. ruling hikes duties on Chinese mobile access equipment to nearly 70%, a win for U.S. firms but a blow to importers and buyers.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.